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Chemicals, including commonly used drugs (e.g., penicillin, meprobamate, pyridium, and mercap-
tomerin) penetrate and persist for some time in the ovarian follicular fluid at concentrations approxi-
mately similar tothat ofthe serum. Information as tothe penetration ofchemicals into the granulosa cells
and into the oocyte isscanty, although there are some indications that these structures are also permeable
to foreign chemicals. Similarly, caffeine, nicotine, thiopental, salicylic acid, antipyrine, barbital, and
isoniazid enter the uterine secretion and penetrate the preimplantation blastocyst of mice, rats and
rabbits. The pattern of distribution ofcompounds among ovarian follicular fluid, uterine luminal fluid,
blastocyst and plasma varies from compound to compound and appears to be related to the molecular
weight and degree ofionization ofthe compound and differs in pregnant and nonpregnant animals. Thus,
nicotine and DDT accumulate in the uterine luminal fluid of pregnant but not in that of nonpregnant
rabbits.
The penetration offoreign chemicals intothe oocyte, uterine luminal fluid, and preimplantation blasto-
cyst may exert adverse effects on fertilization, implantation, and/or further development oftheconceptus.
The possible toxicological importance of this process to eutherian reproduction is discussed.
It has been well established that many chemicals,
including drugs, are transferred from the maternal
body compartments to the conceptus during its in-
trauterine life. However, it is apparent from the lit-
erature that most ofthe information available is re-
lated to the passage of drugs across the placenta in
late pregnancy. Much less is known about the
transfer ofcompounds across the early placentation
when the conceptus, at the embryonic stage, is sen-
sitive to the teratogenic action of chemicals (1-3).
It has become increasingly evident that drugs
given to the mother can also affect the development
of the conceptus during the stages of pregnancy
which precede implantation. Drugs and other
chemicals administered to the mother are known to
prevent implantation (4), cause degenerative
changes in the blastocyst (5), alter the blastocyst
protein profile (6), or adversely affect the develop-
ment of the free blastocyst (7). There is also some
concern that reproduction may be affected by en-
* Departments of Obstetrics and Gynecology and Pharmacol-
ogy, The George Washington University, Washington, D. C.
20037.
vironmental agents before fertilization, since
foreign chemicals not only are readily transferred
into the gonads, but they may persist in these or-
gans for relatively long periods after exposure. For
example, following a single dose of DDT given to
pregnant New Zealand rabbits, DDT and some ofits
metabolites penetrated the maternal ovaries and
persisted there for at least 17 days after exposure.
Even at that time, the concentration of DDT in the
ovaries was almost 80 times higher than in the
plasma (8).
The maturing ovarian follicle is an avascular
structure, regardless of follicular size or state of
follicular maturation (9, 10). Therefore, every
molecule destined to enter the follicle must leave the
vascular bed ofthe perifollicular region and cross the
thecal layer before entering the foilicular fluid and/or
the granulosa cells. To reach the oocyte, molecules
may either be transported by the granulosa cells or
they may advance passively in follicular fluid
through the intercellular spaces and/or the antrum.
At the beginning ofthe century, it was found that
occlusion of the ovarian vein causes a doubling of
follicular size and often rupture of the follicle in a
matter of seconds (11). This observation suggested
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barrier between blood and follicular fluid. Early ex-
periments, showing that Evans blue, S35, and p32
were found in the follicular fluid soon after par-
enteral administration (12, 13) confirmed this hy-
pothesis. In 1958 it was shown that tritiated water
(14) and some commonly used drugs including mep-
robamate, penicillin, pyridium, and mercaptomerin
rapidly equilibrated between blood and follicular
fluid when administered orally or parenterally to
women (15). High molecular weight compounds
(e.g., 1131 y-globulin) also penetrate the follicular
fluid (16), and recently it has been shown that the
blood-follicle barrier behaves like a molecular
sieve, allowing passage of proteins in inverse pro-
portion to their molecular weight (17).
Information as to the penetration of chemicals
into the granulosa cells and into the oocyte is
scanty, although there is some evidence that these
structures are also permeable to foreign chemicals
(18-20). Moreover, Glass (16) has shown that albu-
min and a-globulin penetrate the oocyte, but that,8-
and y-globulins do not.
These results, although incomplete, certainly
suggest that all the components of the ovarian folli-
cles are readily permeable to endogenous as well as
exogenous chemicals. It is likely that a process of
simple diffusion, at least for the small molecular
weight foreign compounds, is involved. However,
the importance of physicochemical characteristics
(i.e., lipid solubility and degree of ionization) in de-
termining the rate and degree ofentry has still to be
clarified.
A few reports have described the passage of
chemicals into the oviduct and into the conceptus
during the premorula stages of pregnancy (21, 22);
relattively more information is available on this pro-
cess after the conceptus has entered the uterine
cavity and become a blastocyst.
Some of the first indications that substances can
pass from the maternal circulation into the
preimplantation blastocyst derived from observa-
tions by Greenwald and Everett (23) and Lutwak-
Mann, Bournsnell, and Bennett (24). The former
workers demonstrated the uptake and incorporation
of35S-methionine by preimplantation blastocysts of
mice treated parenterally with this compound.
Lutwak-Mann's group showed passage of 32PO4,
42K, 35SO4, 24Na, and 131I into endometrial fluids and
preimplantation blastocysts of rabbits receiving
these ions parenterally.
In our laboratory, we have shown that, following
the oral or parenteral administration of radioactive
caffeine, nicotine, salicylate, isoniazid, antipyrine,
barbital, thiopental, and DDT, significant amounts
of the unchanged compounds as well as some of
their metabolites are present in the uterine fluid of
rabbits, rats, and mice (25, 26). Most of the small
molecular weight chemicals attained concentrations
in the uterine fluid similar to those of the plasma at
the corresponding times. Larger molecular weight
compounds (i.e., insulin and dextrans) did not pass
into the uterine fluid readily. It would appear that
passage offoreign chemicals into the uterine fluid is
influenced by the molecular weight of the com-
pounds, as well as by their degree of ionization at
physiological pH (27). Similar results were obtained
by Conner and Miller (28), who studied the passage
of 3H20, barbital, tetraethylammonium bromide,
a-aminoisobutyric acid, tetraethylammonium di-
methyloxazolidinedione, ouabain, insulin, and an-
tipyrine into the uterine luminal fluid of the rat.
They showed that the distribution of compounds
into luminal fluids correlated in a general way with
lipid solubility at pH 7.4 and that no special trans-
port systems were involved in the transfer of the
substances studied.
Foreign chemicals pass into the secretion of sev-
eral exocrine glands (e.g., saliva, bile, sweat, tears,
milk, and seminal fluid) and this transfer is depen-
dent upon the pH of the secretion (29, 30), the mo-
lecular weight (31), and the degree of ionization of
the compound: (32, 33). It was not unexpected,
therefore, that these factors can also influence the
passage of chemicals into the uterine fluid which is
primarily a product of exocrine glands.
One ofthe most intriguing observations we made
in these studies was that pregnancy may modify the
degree to which- drugs pass into the uterine fluid.
For most ofthe compounds examined the degree of
transfer into the uterine fluid was not different in
nonpregnant and 6-day pregnant rabbits (34). How-
ever, this was not the case for nicotine and DDT,
which accumulate in the uterine luminal fluid of
6-day pregnant rabbits but not in that of nonpreg-
nant does similarly treated (35). For example, 30
min after intravenous treatment of 6-day pregnant
rabbits with 3H-nicotine (50 gg/kg), 36-fold higher
concentrations ofunchanged nicotine were found in
uterine fluid than in plasma. Cotinine, a major
metabolite of nicotine, also accumulated in uterine
fluid, but to a lesser extent. In contrast, the con-
centration ofunchanged nicotine in uterine fluid ap-
proximated that in plasma of similarly treated non-
pregnant rabbits (35).
The mechanism by which nicotine accumulates in
the uterine fluid ofpregnant rabbits has intrigued us
for some time. We first attempted to determine
whether apHgradient between the uterine fluid and
plasma of 6-day pregnant rabbits could account for
the accumulation of nicotine in the uterine fluid,
since this mechanism has been used to explain the
Environmental Health Perspectives 26accumulation of ephedrine in the milk (33) and
quinine in the gastric fluid (29). However, the pH of
uterine fluid of 6-day pregnant animals (pH 7.68) is
not significantly different from that of nonpregnant
animals (pH 7.61) (36), ruling out this postulated
mechanism for the accumulation of nicotine in the
pregnant uterine fluid. These findings are in agree-
ment with those of others who have reported ac-
cumulation of foreign chemicals in the secretion of
exocrine glands which cannot be explained by a pH
gradient. For example, the milk/plasma concentra-
tion ratio for quinine and erythromycin has been
reported to be 4.8 and 8.7, respectively (33, 37);
urea reaches levels in human sweat two to four
times that of plasma (38) despite the absence of pH
gradients between the compartments.
We were also unable to demonstrate any differ-
ence in the physiological disposition of nicotine
between 6-day pregnant and nonpregnant does
which could account for the accumulation of
nicotine in the pregnant uterine fluid. Thus, the vol-
ume of distribution, plasma half-life, rate of metab-
olism, urinary excretion, and plasma protein bind-
ing of nicotine are similar in pregnant and nonpreg-
nant animals (35).
These findings indicate that the endometrial tis-
sue in the functional stage of pregnancy influences
the active transfer of nicotine into the uterine fluid.
This hypothesis is supported by the fact that the
accumulation of nicotine seen in the 6-day pregnant
rabbit can be reproduced by pretreating nonpregnant
rabbits with either human chorionic gonadotrophin
or progesterone (35).
Parenterally and orally administered drugs and
other chemicals not only enter the endometrial fluid
but also penetrate the free-lying blastocyst. Sodium
thiocyanide, sulfonamide, and salicylate (39, 40),
thalidomide (41-43), as well as DDT, isoniazid, bar-
bital and thiopental, caffeine and nicotine (26, 34)
have been identified in blastocysts of the rabbit fol-
lowing maternal treatment. Experiments in vitro
showed that dextran of 60,000 to 90,000 molecular
weight does not penetrate the 6-day rabbit blasto-
cyst, whereas 12 other compounds of smaller
molecular weight, including 16,000 to 19,000
molecular weight dextran, salicylate, sulfanilamide,
antipyrine, and hexamethonium, enter the blasto-
cyst at a rate which seems dependent upon their
lipid solubility and degree of ionization.
Although it is clear from these findings that the
preimplantation blastocyst is permeable to numer-
ous foreign compounds, additional studies are
necessary to clarify the mechanisms by which these
substances enter the free-lying blastocyst and dis-
tribute themselves.
It is of interest in this respect that when 6-day
preimplantation rabbit blastocysts were incubated
for 60 min in a medium containing 14C-DDT, the
embryonic disc with its associated zona-coated
trophoblast contained a concentration of DDT
which was approximately fivefold that of the blas-
tocoelic fluid, which by this time had equilibrated
with the medium (35). In view of these results, it
would be interesting to know whether compounds
such as 6-mercaptopurine, actinomycin D, and
thalidomide, which have been shown to cause ab-
normalities of the embryonic disc and trophoblast
(44) preferentially accumulate in these tissues.
The presence ofa number offoreign chemicals in
the preimplantation blastocyst following maternal
exposure has raised the obvious question of the
toxicological significance of these findings.
In our laboratory, we have administered daily
doses of caffeine (25 mg/kg, orally), salicylate (100
mg/kg, orally), DDT (1 mg/kg, orally), and nicotine
(0.1 mg/kg, intravenously) to pregnant New Zealand
White rabbits on days 4 through 7 of gestation and
evaluated the outcome of pregnancy. Neither caf-
feine nor salicylate, administered to rabbits during
the preimplantation stages of pregnancy, appeared
to exert any toxic effects on the conceptus. Treat-
ment with nicotine did not reduce the number of
implantations or the volume of the conceptus at 8
days, although the average weight of the offspring
recovered at 28 days of pregnancy was significantly
(p < 0.05) lower than control fetuses. It has been
shown that women who smoke have a higher spon-
taneous abortion rate (45), and the babies they de-
liver are more likely to be premature (46) and have
relatively lower birth weights (47). Whether this
type ofhuman toxicity has any relationship to expo-
sure to nicotine during the preimplantation stages of
pregnancy remains to be assessed.
Treatment with DDT during the preimplantation
stages of pregnancy did not decrease the number of
implantations, but the average volume of the im-
planted embryos at 8 days of pregnancy was signif-
icantly less than that of the controls. As in the case
of nicotine, the 28-day fetuses of the DDT-treated
rabbits were significantly smaller than those of the
control group. In addition, brain weights of the
DDT-exposed fetuses were significantly lower than
the brain weights of the control animals. These ef-
fects were not seen with caffeine, salicylate, or
nicotine. Since Wigglesworth (48) and Harding and
Shelley (49) have reported that during intrauterine
life the increasing brain weight of rat and rabbit
fetuses parallels gestational age and is relatively in-
dependent of the total body weight of the concep-
tus, the decrease in fetal brain weight of DDT-
treated animals may be of significance.
This may well be an indication that, at least in the
June 1978 27rabbit, DDT exposure during the preimplantation
stages of pregnancy exerts a toxic action which is
manifested by intrauterine growth retardation. It
has been reported that DDT causes prematurity and
intrauterine growth retardation when given in large
amounts to pregnant rabbits during morphogenesis
(50), and low birth weights in human infants have
been correlated with high serum levels of DDE, a
major metabolite of DDT (51). Thus, our results in
the rabbit seem to indicate that exposure of the
mother during the preimplantation stages of preg-
nancy to some commonly encountered environ-
mental agents such as nicotine and DDT may result
in a type of toxicity manifested by intrauterine
growth retardation in the absence of teratogenesis
(27).
REFERENCES
1. Brambell, F. W. R. The transmission of immunity from
mother to young and the catabolism of immunoglobulins,
Lancet 2: 1087 (1966).
2. Fabro, S., Smith, R. L., and Williams, R. T. The fate of
(14C)-thalidomide in the pregnant rabbit. Biochem. J. 104:
565 (1967).
3. Keberle, H., et al. Ueber die penetration von korperfremden
Stoffen in denjungen Wirbeltierkeim. Bull. Schweiz. Akad.
Med. Wiss. 22: 134 (1966).
4. Chang, M. C. Effects of certain antifertility agents on the
development of rabbit ova. Fertil. Steril. 15: 97 (1964).
5. Lutwak-Mann, C., and Hay, M. F. Effect on the early em-
bryo of agents administered to the mother. Brit. Med. J. 2:
944 (1962). ,
6. McLachlan, J. A., Dames, N. M., and Fabro, S. Abnormal
protein profile in rabbit embryos after maternal exposure to
some common environmental chemicals. Fed. Proc. 29: 348
(1970).
7. Adams, C. E., Hay, M. F., and Lutwak-Mann, C. The action
of various agents upon the rabbit embryo. J. Embryol.
Exptl. Morphol. 9: 468 (1961).
8. Hart, M. M., et al. Distribution and effects of DDT in the
pregnant rabbit. Xenobiotica 2: 567 (1972).
9. Hertig, A. T., and Adams, E. C. Studies on the human oo-
cyte and its follicle. 1. Ultrastructural and histochemical ob-
servations of the primordial follicle stage. J. Cell Biol. 34:
647 (1967).
10. Odor, D. L., and Blandau, R. J. Ultrastructural studies on
fetal and early postnatal mouse ovaries. II. Cytodifferentia-
tion. Am. J. Anat. 125: 177 (1969).
11. Clark, J. G. Johns Hopkins Hosp. Repts. 9: 593 (1900).
12. Zachariae, F. Studies on the mechanism of ovulation: per-
meability of the blood-liquor barrier. Acta Endocrinol. 27:
339 (1958).
13. Gothie, S. Etude comparee de la repartition du 32P et du 35S
dans l'organisme de lapine, specialement dans l'ovaire.
C. R. Seances Soc. Biol. Paris 148: 1210 (1954).
14. Peckham, B., and Kiekhofer, W. The movement of tritium-
labeled water in the human ovarian follicle. Am. J. Obstet.
Gynecol. 78: 101 (1959).
15. Von Kaulla, K. N., Aikawa, J. K., and Pettigrew, J. D.
Concentration in the human ovarian follicular fluid of
radioactive tracers and drugscirculating in the blood. Nature
182: 1238 (1958).
16. Glass, L. E. Transmission ofmaternal proteins into oocytes.
Adv. Biosci. 6: 29 (1971).
17. Shalgi, R., et al. Proteins of human follicular fluid: The
blood-follicle barrier. Fertil. Steril. 24: 429 (1973).
18. Odeblad, E., and Bostrom, H. A time-picture relation study
with autoradiography on the uptake of labeled sulphate in
the Graafian follicles ofthe rabbit. Acta Radiologica, 39: 137
(1952).
19. Austin, C. R., and Lovelock, J. Permeability of rabbit, rat
and hamster egg membranes. Exptl. Cell Res. 15: 260(1958).
20. Payer, A. F. Permeability ofovarian follicles and capillaries
in mice. Am. J. Anat. 142: 295 (1975).
21. Glass, L. E., and Hanson, J. E. Transfer and localization of
maternal serum antigens by mouse preimplantation embryos
and oviductal epithelium. Differentiation 4: 15 (1975).
22. Hanscom, D. R., and Oliphant, G. Hormonal regulation of
incorporation of 35S into macromolecules of oviduct fluid.
Biol. Reprod. 14: 599 (1976).
23. Greenwald, G. S., and Everett, N. B. The incorporation of
S35 methionine by the uterus and ova of the mouse. Anat.
Rec. 134: 171 (1959).
24. Lutwak-Mann, C., and Bournsell, J. C., and Bennett, J. P.
Blastocyst-uterine relationships: Uptake of radioactive ions
by the early rabbit embryo and its environment. J. Reprod.
Fertil. 1: 169 (1960).
25. McLachlan, J. A., et al. Studies on the transfer ofdrugs into
the uterine secretion. Fed. Proc. 28: 744 (1969).
26. Sieber, S. M., and Fabro, S. Identification of drugs in the
preimplantation blastocyst and in the plasma, uterine secre-
tion and urine of the pregnant rabbit. J. Pharmacol. Exptl.
Therap. 176: 65 (1971).
27. Fabro, S. Passage of drugs and other chemicals into the
uterine fluids and preimplantation blastocyst. In: Fetal
Pharmacology, A. Boreus, Ed., Raven Press, New York.
1973.
28. Conner, E. A., and Miller, J. W. The distribution ofselected
substances into rat uterine luminal fluid. J. Pharmacol.
Exptl. Therap. 184: 291 (1973).
29. Shore, P. A., Brodie, B. B., and Hogben, C. A. M. The
gastric secretion of drugs: a pH partition hypothesis. J.
Pharmacol. Exptl. Therap. 119: 361 (1957).
30. Shanker, L. S. Absorption of drugs from the rat colon. J.
Pharmacol. Exptl. Therap. 126: 283 (1959).
31. Martin, K., and Burgen, A. S. V. Changes in the permeabil-
ity of the salivary gland caused by sympathetic stimulation
and by catecholamines. J. Gen. Physiol. 46: 225 (1962).
32. Thaysen, J. H., and Schwartz, I. L. The permeability of
human sweat glands to a series of sulfonamide compounds.
J. Exptl. Med. 98: 261 (1953).
33. Sisodia, C. S., and Stowe, C. M. The mechanism of drug
secretion into bovine milk. Ann. N. Y. Acad. Sci. 111: 650
(1964).
34. Fabro, S., and Sieber, S. M. Penetration of drugs into the
rabbit blastocyst before implantation. Excerpta Med. Int.
Congr. Ser. 183: 313 (1968).
35. McLachlan, J. A., et al. Accumulation of nicotine in the
uterine fluid ofthe six-day pregnant rabbit. Fertil. Steril. 27:
1204 (1976).
36. McLachlan, J. A., et al. The pH values of the uterine secre-
tions and pre-implantation blastocyst of the rabbit. Fertil.
Steril. 21: 84 (1970).
37. Rasmussen, F. Mammary excretion of benzyl-penicillin.
erythromycin and penethamate hydrochloride. Acta Phar-
macol. Toxicol. 16: 194 (1959).
38. Bulmer, M. G. The concentration of urea in thermal sweat.
J. Physiol. 137: 261 (1957).
39. Lutwak-Mann, C. Some properties of the rabbit blastocyst.
J. Embryol. Exptl. Morphol. 2: 1 (1954).
28 Environmental Health Perspectives40. Lutwak-Mann, C. Glucose, lactic acid and bicarbonate in
rabbit blastocyst fluid. Nature 193: 653 (1962).
41. Fabro, S., et al. Indentification of thalidomide in rabbit
blastocysts. Nature 201: 1125 (1964).
42. Keberle, H., et al. Biochemical effects of drugs on the
mammalian conceptus. Ann. N. Y. Acad. Sci. 123: 252
(1965).
43. Fabro, S., Smith, R. L., and Williams, R. T. The persistence
ofmaternally administered 14C-thalidomide in the rabbit em-
bryo. Biochem. J. 97: 148 (1965).
44. Lutwak-Mann, C., Hay, M. F., and New, D. A. T. Action of
various agents on rabbit blastocysts in vivo and in vitro. J.
Reprod. Fertil. 18: 235 (1969).
45. O'Lane, J. M. Some fetal effects of maternal cigarette
smoking. Obstet. Gynecol. 22: 181 (1963).
46. Peterson, W. F., Morese, K. N., and Kaltreider, D. F.
Smoking and prematurity. A preliminary report based on
study of7740 Caucasians. Obstet. Gynecol. 26: 775 (1965).
47. Mulcahy, R., Murphy, J., and Martin, F. Placental changes
and maternal weight in smoking and non-smoking mothers.
Am. J. Obstet. Gynecol. 104: 703 (1970).
48. Wigglesworth, J. S. Experimental growth retardation in the
foetal rat. J. Pathol. Bacteriol. 88: 1 (1964).
49. Harding, P. G. R., and Shelley, H. J. Some effects of in-
trauterine growth retardation in the foetal rabbit. In:In-
trauterine Dangers to the Foetus, J. Horsky and Z. K.
Stembera, Eds., Excerpta Medica Foundation, Amsterdam,
1967, p. 529.
50. Hart, M. M., Adamson, R. H., and Fabro, S. Prematurity
and intrauterine growth retardation induced by DDT in the
rabbit. Arch. Int. Pharmacodyn. Therap. 192: 286 (1971).
51. O'Leary, J. A., et al. Correlation of prematurity and DDE
levels in fetal whole blood. Am. J. Obstet. Gynecol. 106: 939
(1970).
June 1978 29